Company Filing History:
Years Active: 1989
Title: Innovations by Hussein Ziad in Sustained Release Tablets
Introduction
Hussein Ziad is an accomplished inventor based in Galil Tahton, IL. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release tablets. His innovative work aims to improve the quality of life for individuals suffering from respiratory conditions.
Latest Patents
Hussein Ziad holds 1 patent for his invention titled "Sustained release tablets of theophylline." This patent describes a sustained release tablet that comprises an admixture of theophylline and denatured egg-albumin. The invention also outlines a process for preparing the tablet and a method for administering it to patients suffering from asthma.
Career Highlights
Hussein Ziad is associated with Yissum Research and Development, where he continues to explore advancements in pharmaceutical formulations. His work is characterized by a commitment to enhancing therapeutic options for patients.
Collaborations
Hussein has collaborated with notable colleagues, including Michael M Friedman and Meir Bialer, who share his dedication to innovation in the pharmaceutical industry.
Conclusion
Hussein Ziad's contributions to the development of sustained release tablets represent a significant advancement in asthma treatment. His innovative approach and collaboration with esteemed colleagues highlight the importance of research and development in improving patient care.